Skip to content

Protection Against Allergy: Study in Rural Environment - Part IV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02929277
Acronym
PATURE IV
Enrollment
131
Registered
2016-10-11
Start date
2013-10-31
Completion date
2015-05-06
Last updated
2018-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Atopy

Keywords

farm children, non-farm children

Brief summary

PASTURE is a birth cohort of children born to farm and non-farm women from rural areas across Europe. Five study centres Austria, Germany, Switzerland, France and Finland enrolled 1133 children (farmers in about half of the children) to study the origins of asthma and atopy and to develop potential preventive strategies. Previous results show a protective effect of farm exposure on allergic risk by livestock contacts and microbial exposures and by raw cow milk consumption in early age. PASTURE Part IV is the 10-year follow up of this birth cohort. The primary objective is to characterize the allergic phenotype between 6 and 10 years old (asthma and allergic rhinitis) and to explain how early age exposures and particularly milk products consumption contribute in the process of allergic illness in childhood. A focus on the characterization of the protective biologically active components in raw milk and identification of immunological mechanisms are involved.

Interventions

OTHERblood sampling, skin prick tests, assesment of atopic dermatitis, questionnaires

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* PATURE IV is a birth cohort. All children enrolled at the beginning and who still agree to participate will be included at 10-year follow-up.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Asthma10 years old
Rhinitis10 years old
Atopic Dermatitis10 years old
Food Allergy10 years old
Skin prick tests10 years old
Specific Immunoglobulin E (IgEs)10 years old
Blood cytokine profiles10 years old

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026